id	sid	eid	entity	type
ijpds-4459	1	1	bhat & shanbhag biomaterials	ORG
ijpds-4459	1	2	3	CARDINAL
ijpds-4459	1	3	2 | apr –	TIME
ijpds-4459	1	4	2024	CARDINAL
ijpds-4459	1	5	indian	NORP
ijpds-4459	1	6	j pharm drug	PRODUCT
ijpds-4459	1	7	37	CARDINAL
ijpds-4459	1	8	ramdas bhat1	PERSON
ijpds-4459	1	9	preeti shanbhag2	PERSON
ijpds-4459	1	10	1associate	CARDINAL
ijpds-4459	1	11	2pg	CARDINAL
ijpds-4459	1	12	srinivas college	PERSON
ijpds-4459	1	13	karnataka	GPE
ijpds-4459	1	14	india	GPE
ijpds-4459	8	1	crispr-cas9	PERSON
ijpds-4459	9	1	ancer	PERSON
ijpds-4459	9	2	one	CARDINAL
ijpds-4459	9	3	millions	CARDINAL
ijpds-4459	9	4	each year	DATE
ijpds-4459	9	5	1	CARDINAL
ijpds-4459	10	1	2	CARDINAL
ijpds-4459	11	1	3	CARDINAL
ijpds-4459	12	1	recent years	DATE
ijpds-4459	12	2	4	CARDINAL
ijpds-4459	12	3	5	CARDINAL
ijpds-4459	13	1	6	CARDINAL
ijpds-4459	14	1	three	CARDINAL
ijpds-4459	15	1	31st jan 2024	DATE
ijpds-4459	15	2	27th feb 2024	DATE
ijpds-4459	15	3	feb 2024	DATE
ijpds-4459	15	4	atezolizumab	GPE
ijpds-4459	15	5	durvalumab	PERSON
ijpds-4459	15	6	ipilimumab	PERSON
ijpds-4459	15	7	cemiplimab	PERSON
ijpds-4459	17	1	lisocabtagenedarolumab	PERSON
ijpds-4459	18	1	9	CARDINAL
ijpds-4459	68	1	ramdas bhat	PERSON
ijpds-4459	68	2	srinivas college	PERSON
ijpds-4459	68	3	karnataka	GPE
ijpds-4459	70	1	+91 7795772463	DATE
ijpds-4459	71	1	mailto:ramdas21@gmail.com bhat & shanbhag	ORG
ijpds-4459	71	2	3	CARDINAL
ijpds-4459	71	3	2 | apr –	TIME
ijpds-4459	71	4	2024	CARDINAL
ijpds-4459	71	5	indian	NORP
ijpds-4459	71	6	j pharm drug	PRODUCT
ijpds-4459	71	7	38	CARDINAL
ijpds-4459	72	1	10-13	CARDINAL
ijpds-4459	73	1	14	CARDINAL
ijpds-4459	74	1	15	CARDINAL
ijpds-4459	75	1	16	CARDINAL
ijpds-4459	76	1	17	CARDINAL
ijpds-4459	77	1	18	CARDINAL
ijpds-4459	78	1	19	CARDINAL
ijpds-4459	78	2	20	CARDINAL
ijpds-4459	78	3	21	CARDINAL
ijpds-4459	82	1	january 2024	DATE
ijpds-4459	89	1	1	CARDINAL
ijpds-4459	89	2	17	CARDINAL
ijpds-4459	91	1	23	CARDINAL
ijpds-4459	92	1	24	CARDINAL
ijpds-4459	93	1	25	CARDINAL
ijpds-4459	93	2	26	CARDINAL
ijpds-4459	95	1	three	CARDINAL
ijpds-4459	97	1	27	CARDINAL
ijpds-4459	99	1	bhat & shanbhag biomaterials	ORG
ijpds-4459	99	2	3	CARDINAL
ijpds-4459	99	3	2 | apr –	TIME
ijpds-4459	99	4	2024	CARDINAL
ijpds-4459	99	5	indian	NORP
ijpds-4459	99	6	j pharm drug	PRODUCT
ijpds-4459	99	7	39 2	CARDINAL
ijpds-4459	100	1	28	CARDINAL
ijpds-4459	102	1	one	CARDINAL
ijpds-4459	102	2	29	CARDINAL
ijpds-4459	104	1	31	CARDINAL
ijpds-4459	106	1	32	CARDINAL
ijpds-4459	108	1	33	CARDINAL
ijpds-4459	110	1	3	CARDINAL
ijpds-4459	111	1	3437	CARDINAL
ijpds-4459	112	1	35,36	CARDINAL
ijpds-4459	115	1	35	CARDINAL
ijpds-4459	118	1	34	CARDINAL
ijpds-4459	120	1	1	CARDINAL
ijpds-4459	122	1	crispr-cas9 technology	ORG
ijpds-4459	124	1	12,13	CARDINAL
ijpds-4459	125	1	1	CARDINAL
ijpds-4459	126	1	38	CARDINAL
ijpds-4459	127	1	cas9	GPE
ijpds-4459	127	2	39	CARDINAL
ijpds-4459	128	1	three	CARDINAL
ijpds-4459	128	2	40	CARDINAL
ijpds-4459	130	1	bhat & shanbhag biomaterials	ORG
ijpds-4459	130	2	3	CARDINAL
ijpds-4459	131	1	2 | apr –	TIME
ijpds-4459	131	2	2024	CARDINAL
ijpds-4459	131	3	indian	NORP
ijpds-4459	131	4	j pharm drug	PRODUCT
ijpds-4459	131	5	40	CARDINAL
ijpds-4459	132	1	cas9	GPE
ijpds-4459	132	2	41,42	CARDINAL
ijpds-4459	136	1	42	CARDINAL
ijpds-4459	137	1	crisprcas9	ORG
ijpds-4459	138	1	first	ORDINAL
ijpds-4459	138	2	2016	DATE
ijpds-4459	138	3	44	CARDINAL
ijpds-4459	141	1	45	CARDINAL
ijpds-4459	142	1	2	CARDINAL
ijpds-4459	144	1		CARDINAL
ijpds-4459	145	1		CARDINAL
ijpds-4459	145	2	crisprcas9	ORG
ijpds-4459	146	1		CARDINAL
ijpds-4459	147	1		CARDINAL
ijpds-4459	148	1		CARDINAL
ijpds-4459	148	2	crispr	GPE
ijpds-4459	150	1		CARDINAL
ijpds-4459	151	1		CARDINAL
ijpds-4459	152	1		CARDINAL
ijpds-4459	153	1		CARDINAL
ijpds-4459	154	1		CARDINAL
ijpds-4459	154	2	dotap	FAC
ijpds-4459	154	3	dlin-mc3-dma	PERSON
ijpds-4459	157	1	3	CARDINAL
ijpds-4459	158	1	cas9	NORP
ijpds-4459	158	2	42	CARDINAL
ijpds-4459	159	1	nearly 70%	PERCENT
ijpds-4459	165	1	ccr5	ORG
ijpds-4459	166	1	bhat & shanbhag	ORG
ijpds-4459	166	2	3	CARDINAL
ijpds-4459	166	3	2 | apr –	TIME
ijpds-4459	166	4	2024	CARDINAL
ijpds-4459	166	5	indian	NORP
ijpds-4459	166	6	j pharm drug	PRODUCT
ijpds-4459	166	7	41	CARDINAL
ijpds-4459	166	8	48	CARDINAL
ijpds-4459	167	1	cas9	GPE
ijpds-4459	171	1	46	CARDINAL
ijpds-4459	172	1	4	CARDINAL
ijpds-4459	172	2	49	CARDINAL
ijpds-4459	177	1	48	CARDINAL
ijpds-4459	181	1		CARDINAL
ijpds-4459	182	1	crisprcas9	ORG
ijpds-4459	182	2	50	CARDINAL
ijpds-4459	183	1		CARDINAL
ijpds-4459	186	1	49,50	CARDINAL
ijpds-4459	187	1		CARDINAL
ijpds-4459	189	1	51	CARDINAL
ijpds-4459	190	1		CARDINAL
ijpds-4459	191	1	52	CARDINAL
ijpds-4459	192	1	40	CARDINAL
ijpds-4459	195	1	f.	PERSON
ijpds-4459	197	1	41,42	CARDINAL
ijpds-4459	201	1	20,35,36	CARDINAL
ijpds-4459	202	1	bhat & shanbhag biomaterials	ORG
ijpds-4459	202	2	3	CARDINAL
ijpds-4459	202	3	2 | apr –	TIME
ijpds-4459	202	4	2024	CARDINAL
ijpds-4459	202	5	indian	NORP
ijpds-4459	202	6	j pharm drug	PRODUCT
ijpds-4459	202	7	42	CARDINAL
ijpds-4459	207	1	i.	PERSON
ijpds-4459	209	1	20,28,52	CARDINAL
ijpds-4459	210	1	2	CARDINAL
ijpds-4459	212	1	53	CARDINAL
ijpds-4459	214	1	17,54	CARDINAL
ijpds-4459	215	1	17,53,54	CARDINAL
ijpds-4459	217	1	55	CARDINAL
ijpds-4459	219	1	56,57	CARDINAL
ijpds-4459	220	1	57	CARDINAL
ijpds-4459	221	1	58	CARDINAL
ijpds-4459	222	1	crispr-cas9	GPE
ijpds-4459	223	1	59	CARDINAL
ijpds-4459	225	1	bhat & shanbhag	ORG
ijpds-4459	225	2	3	CARDINAL
ijpds-4459	226	1	2 | apr –	TIME
ijpds-4459	226	2	2024	CARDINAL
ijpds-4459	226	3	indian	NORP
ijpds-4459	226	4	j pharm drug	PRODUCT
ijpds-4459	226	5	43	CARDINAL
ijpds-4459	226	6	60	CARDINAL
ijpds-4459	227	1	61	CARDINAL
ijpds-4459	228	1	62	CARDINAL
ijpds-4459	229	1	63	CARDINAL
ijpds-4459	231	1	64	CARDINAL
ijpds-4459	232	1	64	CARDINAL
ijpds-4459	234	1	64,65	CARDINAL
ijpds-4459	243	1	1	CARDINAL
ijpds-4459	244	1	weinberg ra	PERSON
ijpds-4459	247	1	2011	DATE
ijpds-4459	247	2	144(5):646-74	DATE
ijpds-4459	248	1	2	CARDINAL
ijpds-4459	248	2	miller kd	PERSON
ijpds-4459	248	3	nogueira l	ORG
ijpds-4459	250	1	j clin	PERSON
ijpds-4459	251	1	2019	DATE
ijpds-4459	251	2	69(5):363-85	DATE
ijpds-4459	252	1	3	CARDINAL
ijpds-4459	253	1	sharma p	PERSON
ijpds-4459	253	2	allison jp	PERSON
ijpds-4459	255	1	2015	CARDINAL
ijpds-4459	255	2	161(2):205-14	DATE
ijpds-4459	256	1	4	CARDINAL
ijpds-4459	256	2	mellman	PERSON
ijpds-4459	256	3	coukos g	PERSON
ijpds-4459	256	4	dranoff g.	PERSON
ijpds-4459	258	1	2011	DATE
ijpds-4459	258	2	480(7378):480-9	DATE
ijpds-4459	259	1	chylinski k	PERSON
ijpds-4459	262	1	2012	DATE
ijpds-4459	262	2	337(6096):816-21	DATE
ijpds-4459	263	1	6	CARDINAL
ijpds-4459	263	2	topalian sl	PERSON
ijpds-4459	263	3	drake cg	PERSON
ijpds-4459	263	4	pardoll dm	PERSON
ijpds-4459	265	1	2015	CARDINAL
ijpds-4459	265	2	27(4):450-61	DATE
ijpds-4459	266	1	7	CARDINAL
ijpds-4459	266	2	brahmer jr, tykodi ss	PERSON
ijpds-4459	266	3	anti-pd-l1	NORP
ijpds-4459	267	1	2012	DATE
ijpds-4459	267	2	366(26):2455-65	DATE
ijpds-4459	267	3	8	CARDINAL
ijpds-4459	268	1	porter dl	PERSON
ijpds-4459	268	2	levine bl	PERSON
ijpds-4459	268	3	kalos m	PERSON
ijpds-4459	269	1	2011	DATE
ijpds-4459	269	2	365(8):725-33	DATE
ijpds-4459	270	1	9	CARDINAL
ijpds-4459	270	2	sahin u	PERSON
ijpds-4459	270	3	derhovanessian e	PERSON
ijpds-4459	270	4	miller m	ORG
ijpds-4459	272	1	2017	CARDINAL
ijpds-4459	272	2	547(7662):222-6	DATE
ijpds-4459	272	3	10	CARDINAL
ijpds-4459	273	1	vinay ds	PERSON
ijpds-4459	273	2	ryan ep	PERSON
ijpds-4459	275	1	2015	CARDINAL
ijpds-4459	275	2	35	CARDINAL
ijpds-4459	276	1	11	CARDINAL
ijpds-4459	277	1	burrell ra	PERSON
ijpds-4459	277	2	bartek j	PERSON
ijpds-4459	280	1	2013	DATE
ijpds-4459	280	2	501(7467):338-45	DATE
ijpds-4459	280	3	12	CARDINAL
ijpds-4459	281	1	doudna ja	PERSON
ijpds-4459	281	2	charpentier e.	PERSON
ijpds-4459	283	1	2014	DATE
ijpds-4459	284	1	346(6213):1258096	CARDINAL
ijpds-4459	285	1	13	CARDINAL
ijpds-4459	285	2	hsu pd	PERSON
ijpds-4459	285	3	zhang f. development	PERSON
ijpds-4459	287	1	2014	DATE
ijpds-4459	287	2	157(6):1262-78	CARDINAL
ijpds-4459	288	1	14	CARDINAL
ijpds-4459	289	1	garraway la	PERSON
ijpds-4459	291	1	2013	DATE
ijpds-4459	291	2	153(1):17-37	DATE
ijpds-4459	292	1	15	CARDINAL
ijpds-4459	293	1	wilhelm s	PERSON
ijpds-4459	293	2	tavares aj	PERSON
ijpds-4459	293	3	dai	ORG
ijpds-4459	295	1	nat rev mater	PERSON
ijpds-4459	295	2	2016	CARDINAL
ijpds-4459	295	3	1:16014	CARDINAL
ijpds-4459	296	1	16	CARDINAL
ijpds-4459	297	1	hutmacher dw	PERSON
ijpds-4459	297	2	lam cx	PERSON
ijpds-4459	299	1	2007	DATE
ijpds-4459	299	2	1(4):245-60	DATE
ijpds-4459	299	3	17	CARDINAL
ijpds-4459	300	1	stephan sb	PERSON
ijpds-4459	300	2	taber am	PERSON
ijpds-4459	300	3	jileaeva	PERSON
ijpds-4459	301	1	biopolymer	PERSON
ijpds-4459	302	1	nat biotechnol	PERSON
ijpds-4459	303	1	2015	DATE
ijpds-4459	304	1	33(1):97	CARDINAL
ijpds-4459	304	2	18	CARDINAL
ijpds-4459	305	1	smith tt	PERSON
ijpds-4459	305	2	stephan sb	PERSON
ijpds-4459	305	3	moffett hf	PERSON
ijpds-4459	307	1	nat nanotechnol	PERSON
ijpds-4459	307	2	2017	CARDINAL
ijpds-4459	307	3	12(8):813-20	CARDINAL
ijpds-4459	308	1	ec	ORG
ijpds-4459	308	2	huang x	PERSON
ijpds-4459	310	1	2012	DATE
ijpds-4459	310	2	41(7):2740-79	DATE
ijpds-4459	310	3	20	CARDINAL
ijpds-4459	311	1	25th	ORDINAL
ijpds-4459	312	1	adv mater	PERSON
ijpds-4459	313	1	2014	DATE
ijpds-4459	314	1	26(1):85	CARDINAL
ijpds-4459	315	1	21	CARDINAL
ijpds-4459	316	1	wang h	PERSON
ijpds-4459	316	2	crispr	PERSON
ijpds-4459	317	1	annu rev biochem	ORG
ijpds-4459	318	1	2016	CARDINAL
ijpds-4459	318	2	85:227-64	DATE
ijpds-4459	319	1	bhat & shanbhag biomaterials	ORG
ijpds-4459	319	2	3	CARDINAL
ijpds-4459	319	3	2 | apr –	TIME
ijpds-4459	319	4	2024	CARDINAL
ijpds-4459	319	5	indian	NORP
ijpds-4459	319	6	j pharm drug	PRODUCT
ijpds-4459	319	7	44 22	DATE
ijpds-4459	320	1	cunningham n	PERSON
ijpds-4459	320	2	lerouge s. biomaterials	ORG
ijpds-4459	321	1	apl bioeng	PERSON
ijpds-4459	321	2	2022	CARDINAL
ijpds-4459	321	3	6(4).121548	CARDINAL
ijpds-4459	322	1	23	CARDINAL
ijpds-4459	323	1	kamaly n	PERSON
ijpds-4459	323	2	xiao z	PERSON
ijpds-4459	323	3	valencia pm	PERSON
ijpds-4459	324	1	2012	DATE
ijpds-4459	324	2	41(7):2971-3010	CARDINAL
ijpds-4459	325	1	24	CARDINAL
ijpds-4459	326	1	shi j	PERSON
ijpds-4459	326	2	wang l	PERSON
ijpds-4459	326	3	zhang s	PERSON
ijpds-4459	328	1	2020	DATE
ijpds-4459	329	1	5(4):38	CARDINAL
ijpds-4459	330	1	25	CARDINAL
ijpds-4459	330	2	topalian sl	PERSON
ijpds-4459	330	3	hodi fs	PERSON
ijpds-4459	330	4	brahmer jr	PERSON
ijpds-4459	331	1	j clin oncol	PERSON
ijpds-4459	332	1	2012	DATE
ijpds-4459	333	1	30(17):2112	CARDINAL
ijpds-4459	333	2	26	CARDINAL
ijpds-4459	334	1	palucka k	PERSON
ijpds-4459	334	2	ueno h	GPE
ijpds-4459	334	3	fay j	ORG
ijpds-4459	336	1	immunol	PERSON
ijpds-4459	337	1	2010	DATE
ijpds-4459	337	2	28:237-69	DATE
ijpds-4459	338	1	27	CARDINAL
ijpds-4459	339	1	kim j	PERSON
ijpds-4459	339	2	kim	PERSON
ijpds-4459	341	1	2022	CARDINAL
ijpds-4459	341	2	14(9):1908	CARDINAL
ijpds-4459	342	1	28	CARDINAL
ijpds-4459	343	1	chen z	PERSON
ijpds-4459	343	2	yue z	PERSON
ijpds-4459	343	3	wang	PERSON
ijpds-4459	345	1	2022	CARDINAL
ijpds-4459	345	2	13:979469. 29	DATE
ijpds-4459	346	1	li y,	PERSON
ijpds-4459	346	2	li s	PERSON
ijpds-4459	346	3	jiang z	PERSON
ijpds-4459	347	1	j nanobiotechnol	PERSON
ijpds-4459	348	1	2023	CARDINAL
ijpds-4459	348	2	21(1):212	CARDINAL
ijpds-4459	349	1	30	CARDINAL
ijpds-4459	350	1	bezbaruah r	PERSON
ijpds-4459	350	2	chavda vp	PERSON
ijpds-4459	350	3	nongrang l	ORG
ijpds-4459	352	1	2022	CARDINAL
ijpds-4459	353	1	10(11):1946	CARDINAL
ijpds-4459	353	2	31	CARDINAL
ijpds-4459	355	1	nat rev	PERSON
ijpds-4459	356	1	2012	DATE
ijpds-4459	356	2	12(4):237-51	CARDINAL
ijpds-4459	358	1	zhang r	PERSON
ijpds-4459	358	2	billingsley mm	PERSON
ijpds-4459	358	3	mitchell mj	PERSON
ijpds-4459	360	1	2018	DATE
ijpds-4459	360	2	292:256-76	CARDINAL
ijpds-4459	361	1	33	CARDINAL
ijpds-4459	362	1	gonzalez	PERSON
ijpds-4459	362	2	werb z.	PERSON
ijpds-4459	363	1	2018	DATE
ijpds-4459	363	2	32(19–20):1267-84	CARDINAL
ijpds-4459	364	1	olson dj	PERSON
ijpds-4459	364	2	k. adoptive	PERSON
ijpds-4459	365	1	j clin oncol	PERSON
ijpds-4459	366	1	2023	CARDINAL
ijpds-4459	366	2	41(18):3397	CARDINAL
ijpds-4459	367	1	35	CARDINAL
ijpds-4459	368	1	rosenberg sa	PERSON
ijpds-4459	368	2	restifo np	PERSON
ijpds-4459	368	3	yang jc	PERSON
ijpds-4459	369	1	nat rev	PERSON
ijpds-4459	369	2	2008	DATE
ijpds-4459	369	3	8(4):299	CARDINAL
ijpds-4459	370	1	36	CARDINAL
ijpds-4459	371	1	kirtane k	PERSON
ijpds-4459	371	2	chung ch	PERSON
ijpds-4459	373	1	2021;9(7):e002723	CARDINAL
ijpds-4459	374	1	37	DATE
ijpds-4459	377	1	2022	CARDINAL
ijpds-4459	377	2	27(3):210-9	DATE
ijpds-4459	377	3	38	CARDINAL
ijpds-4459	378	1	doudna ja	PERSON
ijpds-4459	378	2	charpentier e.	PERSON
ijpds-4459	380	1	2014	DATE
ijpds-4459	380	2	346(6213	CARDINAL
ijpds-4459	381	1	39	CARDINAL
ijpds-4459	382	1	wang m	PERSON
ijpds-4459	382	2	zuris ja	PERSON
ijpds-4459	382	3	meng f	PERSON
ijpds-4459	383	1	sci usa.	ORG
ijpds-4459	383	2	2016	CARDINAL
ijpds-4459	383	3	113(11):2868–73. 40	DATE
ijpds-4459	384	1	pan x	PERSON
ijpds-4459	384	2	su n	PERSON
ijpds-4459	385	1	asian	NORP
ijpds-4459	385	2	sci	ORG
ijpds-4459	385	3	2021	CARDINAL
ijpds-4459	385	4	16(6):687–703	CARDINAL
ijpds-4459	385	5	41	CARDINAL
ijpds-4459	386	1	chen g	PERSON
ijpds-4459	386	2	abdeen aa	PERSON
ijpds-4459	386	3	wang y	PERSON
ijpds-4459	387	1	cas9	GPE
ijpds-4459	388	1	nat nanotechnol	PERSON
ijpds-4459	388	2	2019	DATE
ijpds-4459	388	3	14(10):974–80	CARDINAL
ijpds-4459	388	4	42	DATE
ijpds-4459	389	1	sahel dk	PERSON
ijpds-4459	389	2	vora lk	PERSON
ijpds-4459	389	3	crispr	PERSON
ijpds-4459	390	1	adv sci	PERSON
ijpds-4459	391	1	2023;10(19	CARDINAL
ijpds-4459	394	1	liang	PERSON
ijpds-4459	394	2	li f	PERSON
ijpds-4459	394	3	wang l	PERSON
ijpds-4459	397	1	2017	CARDINAL
ijpds-4459	398	1	147:68–85. 44	DATE
ijpds-4459	399	1	duan l	PERSON
ijpds-4459	399	2	ouyang k	PERSON
ijpds-4459	402	1	2021	CARDINAL
ijpds-4459	402	2	12	CARDINAL
ijpds-4459	403	1	iqbal z	PERSON
ijpds-4459	403	2	rehman k	PERSON
ijpds-4459	403	3	xia j	PERSON
ijpds-4459	404	1	biomater sci	PERSON
ijpds-4459	404	2	2023	CARDINAL
ijpds-4459	404	3	11(11):3762–83	CARDINAL
ijpds-4459	405	1	46	DATE
ijpds-4459	406	1	yin x	PERSON
ijpds-4459	406	2	mcpherson dd	PERSON
ijpds-4459	407	1	j mol sci	PERSON
ijpds-4459	407	2	2023	CARDINAL
ijpds-4459	407	3	24(16):12844	CARDINAL
ijpds-4459	407	4	47	CARDINAL
ijpds-4459	408	1	nsairat h	ORG
ijpds-4459	408	2	sayed u	PERSON
ijpds-4459	410	1	2022	CARDINAL
ijpds-4459	410	2	8(5):e09394	DATE
ijpds-4459	410	3	48	DATE
ijpds-4459	411	1	wang d	PERSON
ijpds-4459	411	2	tai pwl	PERSON
ijpds-4459	411	3	gao g. adeno	PERSON
ijpds-4459	412	1	nat rev drug discov.	PERSON
ijpds-4459	413	1	2019;18(5):358–78	ORG
ijpds-4459	413	2	49	DATE
ijpds-4459	414	1	zakrzewski w	PERSON
ijpds-4459	414	2	dobrzyński m	PERSON
ijpds-4459	414	3	rybak	PERSON
ijpds-4459	418	1	2019;10(1	CARDINAL
ijpds-4459	419	1	50	DATE
ijpds-4459	420	1	weng z	PERSON
ijpds-4459	420	2	liu y	PERSON
ijpds-4459	421	1	2023;19(8):2557–75	CARDINAL
ijpds-4459	422	1	51	DATE
ijpds-4459	423	1	valenti mt	PERSON
ijpds-4459	423	2	serena m	PERSON
ijpds-4459	423	3	carbonare ld	ORG
ijpds-4459	423	4	crispr	PERSON
ijpds-4459	425	1	2019	CARDINAL
ijpds-4459	426	1	11(11):937–56	CARDINAL
ijpds-4459	427	1	xu cl	PERSON
ijpds-4459	427	2	ruan mzc	PERSON
ijpds-4459	427	3	mahajan	GPE
ijpds-4459	429	1	2019	DATE
ijpds-4459	429	2	11(1):28	CARDINAL
ijpds-4459	430	1	53	CARDINAL
ijpds-4459	431	1	alshangiti dm	PERSON
ijpds-4459	431	2	el-damhougy	GPE
ijpds-4459	432	1	rsc adv	PERSON
ijpds-4459	432	2	2023	CARDINAL
ijpds-4459	432	3	13(50):35251–91	CARDINAL
ijpds-4459	433	1	54	DATE
ijpds-4459	433	2	diaz-galbarriatu	PERSON
ijpds-4459	435	1	2023	CARDINAL
ijpds-4459	435	2	13(12):1981	CARDINAL
ijpds-4459	435	3	55	CARDINAL
ijpds-4459	436	1	yousefpour p	PERSON
ijpds-4459	436	2	ni k	PERSON
ijpds-4459	436	3	irvine	GPE
ijpds-4459	438	1	bioeng	PERSON
ijpds-4459	439	1	2023 jan 30;1(2):107–24.	DATE
ijpds-4459	440	1	56	CARDINAL
ijpds-4459	441	1	roy k	PERSON
ijpds-4459	441	2	keselowsky bg	PERSON
ijpds-4459	442	1	mrs bull	PERSON
ijpds-4459	442	2	2014	DATE
ijpds-4459	442	3	39(1):25–34	CARDINAL
ijpds-4459	443	1	han x	PERSON
ijpds-4459	446	1	2022	CARDINAL
ijpds-4459	447	1	17:29–48	CARDINAL
ijpds-4459	448	1	58	CARDINAL
ijpds-4459	449	1	mariani e	PERSON
ijpds-4459	449	2	lisignoli g	PERSON
ijpds-4459	451	1	j. mol.	PERSON
ijpds-4459	452	1	sci	ORG
ijpds-4459	452	2	2019	DATE
ijpds-4459	452	3	20(3):636	CARDINAL
ijpds-4459	453	1	59	CARDINAL
ijpds-4459	454	1	naeem m	PERSON
ijpds-4459	454	2	majeed s	PERSON
ijpds-4459	457	1	2020	DATE
ijpds-4459	458	1	9(7):1608	CARDINAL
ijpds-4459	459	1	60	CARDINAL
ijpds-4459	460	1	guo c	PERSON
ijpds-4459	460	2	ma x	PERSON
ijpds-4459	460	3	gao f	PERSON
ijpds-4459	462	1	bioeng	PERSON
ijpds-4459	462	2	biotechnol	GPE
ijpds-4459	463	1	2023	CARDINAL
ijpds-4459	463	2	11:1143157. 61	DATE
ijpds-4459	464	1	zhang xh	PERSON
ijpds-4459	464	2	wang xg	PERSON
ijpds-4459	468	1	2015	CARDINAL
ijpds-4459	468	2	4	CARDINAL
ijpds-4459	469	1	62	CARDINAL
ijpds-4459	470	1	ho d	PERSON
ijpds-4459	470	2	mccabe erb	PERSON
ijpds-4459	471	1	biotechnol	GPE
ijpds-4459	472	1	2020	DATE
ijpds-4459	473	1	38(5):497–518	CARDINAL
ijpds-4459	473	2	63	DATE
ijpds-4459	477	1	eng	GPE
ijpds-4459	477	2	2021	CARDINAL
ijpds-4459	477	3	23(1):493-516	CARDINAL
ijpds-4459	479	1	bhat & shanbhag	ORG
ijpds-4459	479	2	3	CARDINAL
ijpds-4459	479	3	2 | apr –	TIME
ijpds-4459	479	4	2024	CARDINAL
ijpds-4459	479	5	indian	NORP
ijpds-4459	479	6	j pharm drug	PRODUCT
ijpds-4459	479	7	45 64	DATE
ijpds-4459	480	1	dubey ak	PERSON
ijpds-4459	480	2	mostafavi e. biomaterials-mediated crispr	ORG
ijpds-4459	482	1	2023	CARDINAL
ijpds-4459	482	2	11	CARDINAL
ijpds-4459	483	1	65	CARDINAL
ijpds-4459	486	1	acs pharmacol	ORG
ijpds-4459	488	1	sci	ORG
ijpds-4459	488	2	2023	CARDINAL
ijpds-4459	488	3	6(12):1758–79	CARDINAL
ijpds-4459	489	1	66	CARDINAL
ijpds-4459	490	1	dai	ORG
ijpds-4459	490	2	blancafort p	PERSON
ijpds-4459	490	3	wang p	PERSON
ijpds-4459	490	4	thompson	ORG
ijpds-4459	490	5	ostrikov k	PERSON
ijpds-4459	490	6	ken	PERSON
ijpds-4459	493	1	sci	ORG
ijpds-4459	493	2	2020	DATE
ijpds-4459	493	3	7(12	CARDINAL
ijpds-4459	494	1	ramdas bhat1	PERSON
ijpds-4459	494	2	preeti shanbhag	PERSON
ijpds-4459	496	1	indian	NORP
ijpds-4459	496	2	2024	CARDINAL
ijpds-4459	496	3	3(2):37-45	DATE